These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10179702)

  • 1. The economic burden of migraine to society.
    Ferrari MD
    Pharmacoeconomics; 1998 Jun; 13(6):667-76. PubMed ID: 10179702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
    Lublóy Á
    BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic impact of migraine: an analysis of direct and indirect costs.
    Edmeads J; Mackell JA
    Headache; 2002 Jun; 42(6):501-9. PubMed ID: 12167138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of migraine. A review of its socioeconomic impact.
    Solomon GD; Price KL
    Pharmacoeconomics; 1997; 11 Suppl 1():1-10. PubMed ID: 10168038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of migraine in Spain: beyond direct costs.
    Badia X; Magaz S; Gutiérrez L; Galván J
    Pharmacoeconomics; 2004; 22(9):591-603. PubMed ID: 15209528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of migraine. A review of cost to society.
    Lipton RB; Stewart WF; Von Korff M
    Pharmacoeconomics; 1994 Sep; 6(3):215-21. PubMed ID: 10155264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic cost of migraine. Present state of knowledge.
    de Lissovoy G; Lazarus SS
    Neurology; 1994 Jun; 44(6 Suppl 4):S56-62. PubMed ID: 8008226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Societal perspective on the burden of migraine in The Netherlands.
    van Roijen L; Essink-Bot ML; Koopmanschap MA; Michel BC; Rutten FF
    Pharmacoeconomics; 1995 Feb; 7(2):170-9. PubMed ID: 10155303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Migraine--a burden for the individual and the society].
    Demarin V; Vuković V
    Acta Med Croatica; 2008 May; 62(2):137-40. PubMed ID: 18710076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan. A pharmacoeconomic review of its use in migraine.
    Coukell AJ; Lamb HM
    Pharmacoeconomics; 1997 May; 11(5):473-90. PubMed ID: 10168035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
    Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
    J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic and social impact of migraine.
    Clarke CE; MacMillan L; Sondhi S; Wells NE
    QJM; 1996 Jan; 89(1):77-84. PubMed ID: 8730346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economics of migraine. Based on a presentation by Stuart O. Schweitzer, PhD.
    Am J Manag Care; 1999 Feb; 5(2 Suppl):S91-8. PubMed ID: 10346519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of migraine: societal costs and therapeutic opportunities.
    Lipton RB; Stewart WF; von Korff M
    Neurology; 1997 Mar; 48(3 Suppl 3):S4-9. PubMed ID: 9071263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and economic impact of migraine.
    Lipton RB; Stewart WF; Scher AI
    Curr Med Res Opin; 2001; 17 Suppl 1():s4-12. PubMed ID: 12463270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of migraine in the United States: disability and economic costs.
    Hu XH; Markson LE; Lipton RB; Stewart WF; Berger ML
    Arch Intern Med; 1999 Apr; 159(8):813-8. PubMed ID: 10219926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.